FDA
-
-
-
-
-
-
-
Therapix Biosciences Provides Update Regarding FSD Acquisition
-
-
-
-
-
-
-
FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a NASDAQ Traded Pharmaceutical Company Focusing on the Development of Cannabinoid-Based Treatments, to Create Medical Cannabis Industry In
-
-
-
-
-
-
-
Therapix Biosciences Updates Regarding TASE Delisting
-
-
-
-
-
-
-
Dual-Listed Therapix to Voluntarily Delist from Tel Aviv Stock Exchange
-
-
-
-
-
-
-
Therapix Biosciences (TRPX) Announces Expansion into Precision Medicine
-
-
-
-
-
-
-
Therapix Biosciences Reports Third Quarter 2017 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Therapix Biosciences and Assuta Medical Center to Initiate Clinical Trial in Obstructive Sleep Apnea
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

